DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

QMS Medical Allied Services Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 3 hrs ago·14 Oct 2026, 2:06 pm

QMS Medical Allied S

QMS Medical Allied Services Limited has confirmed receipt of a compliance certificate for the quarter ending September 30, 2026. This document, issued under SEBI's Depositories and Participants Regulations, verifies that the company has fulfilled its statutory obligations regarding shareholding patterns and corporate actions during this period.

For investors, this filing is a routine administrative update that confirms the company's adherence to regulatory standards. It ensures that the company's shareholding data is accurate and up to date, which is a prerequisite for maintaining a listing on stock exchanges. While this news does not reflect any operational or financial performance, it is a positive signal of compliance.

Moving forward, investors should monitor the company's future quarterly filings to ensure continued regulatory adherence. This filing does not alter the company's business outlook, but it reinforces the importance of regulatory compliance in maintaining market credibility.